Carolinas Wealth Consulting’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding DVAX
DTC
CC
KCM
Carolinas Wealth Consulting's DVAX Position: Q1 2024 in Review
Carolinas Wealth Consulting sold out of Dynavax Technologies (DVAX) in Q1 2024, closing a stake of 33 shares — an estimated $456 sold.
Carolinas Wealth Consulting first reported a position in DVAX in Q4 2022 and held it in 4 quarters. The position peaked at $879 in Q3 2023. 244 funds tracked by Wall St. Rank hold DVAX as of Q1 2024.
- Carolinas Wealth Consulting reported no remaining Dynavax Technologies position as of Q1 2024 after selling out during the quarter.
- Carolinas Wealth Consulting sold 33 Dynavax Technologies shares in Q1 2024, an estimated $456.
- Carolinas Wealth Consulting first reported a position in Dynavax Technologies in Q4 2022 and held it in 4 quarters.
- Carolinas Wealth Consulting's Dynavax Technologies position peaked at $879 in Q3 2023.
- 244 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2024.
Based on Carolinas Wealth Consulting's 13F filing for Q1 2024, filed 15 May 2024.